JPRN-UMIN000008231已完成3 期
A Non-Inferiority Study Evaluating Fibroblast Growth Factor-2 (KCB-1D) to Enamel Matrix Derivative (Emdogain(R)Gel) for Periodontal Tissue Regeneration. - A Non-Inferiority Study Evaluating Fibroblast Growth Factor-2 (KCB-1D) to Enamel Matrix Derivative (Emdogain(R)Gel) for Periodontal Tissue Regeneration.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. coexisting with a malignant tumor or history thereof 2. having taken bisphosphonates or coexisting with osteoporosis 3.coexisting with gingival overgrowth or history of the same 4.suspected of a oral malignant/premalignant tumor 5. determined inappropriate for using Emdogain(R)Gel or participating in this study by investigators 6.coexisting with other dental diseases with potential to cause some effects on periodontal healing at the test site (apical periodontitis or root fractures, etc) 7. scheduled to receive surgical, prosthodontic or endodontic treatments at the test site within 36 weeks 8. with dental prosthesis interrupting accurate evaluation of clinical attachment level 9.with bony defects in need of bone grafts, or suspected of severe gingival recession after flap surgery
研究者
相似试验
招募中
不适用
Study to determine levels of Fibroblast Growth Factor 23 and other associated markers of bone turnover in men with various iron store states of iron overload, iron deficiency and normal iron stores.ACTRN12613000594729Associate Professor Emily Hibbert140
已完成
不适用
The efficacy of fibroblast growth factor for the treatment of chronic vocal fold scarringSymptoms, signs and abnormal clinical and laboratory findings, NECKCT0001855Soon Chun Hyang University Hospital Bucheon17
进行中（未招募）
Unknown
Efficacy of nuclear medicine imaging to detect fibroblast activation protein in pancreatic and biliary tract cancer.NeoplasmsKCT0009207Seoul National University Hospital30
招募中
Unknown
Pilot study of fibroblast activation factor expression in recurrent/progressive pancreatic cancer and mesothelioma using [68Ga]Ga-Fibroblast Activation Protein Inhibitor (FAPI) -46 PET imaging.pancreatic cancerACTRN12623001078640Sir Charles Gairdner and Osborne Park Health Care Group30
已完成
2 期
Phase II study with oral fibroblast growth factor-1 inhibitor BIBF1120 as treatment in lung carcinoma patients harboring fibroblast growth factor receptor-1 gene amplification (NVALT-15 study)NSCLClung cancerNL-OMON44999Stichting NVALT studies40